Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
Organised by the British Society of Blood and Marrow Transplantation and Cellular Therapies (BSBMTCT), this hybrid event offers a practical overview of current and emerging approaches in haematopoietic cell transplantation and cellular therapies.
The programme brings together clinicians, nurses, pharmacists and scientists to discuss developments in CAR-T cell treatment, post-transplant complications, graft-versus-host disease, and late-effects management. Sessions also explore advances in donor selection, conditioning, and data-driven service improvement across UK centres.
Healthcare professionals involved in myeloma care will gain up-to-date learning on the evolving role of transplant and cellular therapies within treatment pathways, and hear expert perspectives on improving outcomes through multidisciplinary collaboration.
